Clinical Trials Logo

Neonatal Seizure clinical trials

View clinical trials related to Neonatal Seizure.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT06308185 Active, not recruiting - Epilepsy Clinical Trials

Neonatal Seizures: Semiology, Etiology, Therapy and Prognosis Correlations

Start date: June 1, 2021
Phase:
Study type: Observational

Epileptic seizures in newborns (often called "neonatal convulsions") represent the most frequent neurological problem in newborns (1-3/1000 newborns). The type of seizure and their etiology is very varied and therefore the therapeutic protocol also requires adaptations with a personalization of the therapeutic approach according to the characteristics of the case according to principles of precision medicine in particular for forms of neonatal epilepsy compared to epileptic seizures acute symptomatic. In recent years it has been highlighted that the clinical characterization and instrumental characterization, in particular electroencephalographic, of epileptic seizures represents an important biomarker that allows the choice of therapy to be oriented appropriately. In the literature there is a lack of single-center studies that relate the type of crisis according to the new ILAE 2017 classification (Fisher 2017) and its proposal for neonatal adaptation (Pressler 2021) with the etiology, type of therapy and outcome neurological after a few years. The primary aim of the study is to evaluate the correlation between the type of seizure determined according to the ILAE classification (clinical variables), the EEG findings of the epileptic seizures and the specific etiology of the epileptic seizures. The secondary aim is to evaluate the correlation between seizure type and etiology with effective therapy, length of hospitalization and neurobehavioral development outcome. The study design is a retrospective observational on the population of neonates managed at our center in the last decade.

NCT ID: NCT04337697 Active, not recruiting - Stroke Clinical Trials

Neonatal Seizure Registry - Developmental Functional EValuation

NSR-DEV
Start date: March 15, 2020
Phase:
Study type: Observational [Patient Registry]

The NSR-DEV study is a longitudinal cohort study of around 280 Neonatal Seizure Registry participants that aims to evaluate childhood outcomes after acute symptomatic neonatal seizures, as well as examine risk factors for developmental disabilities and whether these are modified by parent well-being.

NCT ID: NCT04259125 Active, not recruiting - Epilepsy Clinical Trials

Evaluating the Role of Inflammation in Neonatal Epileptogenesis

NSR-RISE
Start date: December 15, 2018
Phase:
Study type: Observational

The purpose of this study evaluate the relationship between inflammation and epilepsy in neonates with seizures after birth.